tenofovir has been researched along with baricitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Arribas, JR; Borobia, AM; Carcas, AJ; Ciudad, M; de la Calle-Prieto, F; de Miguel, M; Del Álamo, M; Díaz-Brasero, A; Díez, C; Estrada, V; Goikoetxea, AJ; González-Ruano, P; Guijarro, C; Gutiérrez, Á; Ibarra, S; Ibarrola, M; Jiménez-González, M; Marcelo, C; Marcos, J; Martínez, P; Merino, E; Montejano, R; Moreno, S; Novella, M; Queiruga-Parada, J; Rivera, MA; Ruiz-Muñoz, M; Ryan, P; Soler, L; Torralba, M; Velasco, M | 1 |
1 trial(s) available for tenofovir and baricitinib
| Article | Year |
|---|---|
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial.
Topics: Adult; Anti-HIV Agents; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Emtricitabine; HIV Infections; Humans; Tenofovir | 2023 |
1 other study(ies) available for tenofovir and baricitinib
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |